» Articles » PMID: 16971513

Critical Role of PICT-1, a Tumor Suppressor Candidate, in Phosphatidylinositol 3,4,5-trisphosphate Signals and Tumorigenic Transformation

Overview
Journal Mol Biol Cell
Date 2006 Sep 15
PMID 16971513
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) regulates diverse cellular functions by dephosphorylating the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate (PIP(3)). Recent study revealed that PICT-1/GLTSCR2 bound to and stabilized PTEN protein in cells, implicating its roles in PTEN-governed PIP(3) signals. In this study, we demonstrate that RNA interference-mediated knockdown of PICT-1 in HeLa cells down-regulated endogenous PTEN and resulted in the activation of PIP(3) downstream effectors, such as protein kinase B/Akt. Furthermore, the PICT-1 knockdown promoted HeLa cell proliferation; however the proliferation of PTEN-null cells was not altered by the PICT-1 knockdown, suggesting its dependency on PTEN status. In addition, apoptosis of HeLa cells induced by staurosporine or serum-depletion was alleviated by the PICT-1 knockdown in the similar PTEN-dependent manner. Most strikingly, the PICT-1 knockdown in HeLa and NIH3T3 cells promoted anchorage-independent growth, a hallmark of tumorigenic transformation. Furthermore, PICT-1 was aberrantly expressed in 18 (41%) of 44 human neuroblastoma specimens, and the PICT-1 loss was associated with reduced PTEN protein expression in spite of the existence of PTEN mRNA. Collectively, these results suggest that PICT-1 plays a role in PIP(3) signals through controlling PTEN protein stability and the impairment in the PICT-1-PTEN regulatory unit may become a causative factor in human tumor(s).

Citing Articles

Characterization of ferroptosis driver gene signature in head and neck squamous cell carcinoma (HNSC).

Shaikh K, Iqbal Y, Abdel-Maksoud M, Murad A, Badar N, Alarjani K Am J Transl Res. 2023; 15(7):4829-4850.

PMID: 37560204 PMC: 10408515.


NOP53 Suppresses Autophagy through -Dependent and -Independent Pathways.

Cho Y, Kim Y, Lee S, Park J Int J Mol Sci. 2021; 22(17).

PMID: 34502226 PMC: 8430719. DOI: 10.3390/ijms22179318.


In vivo Engineering of Chromosome 19 q-arm by Employing the CRISPR/AsCpf1 and ddAsCpf1 Systems in Human Malignant Gliomas (Hypothesis).

Abak A, Shoorei H, Taheri M, Ghafouri-Fard S J Mol Neurosci. 2021; 71(8):1648-1663.

PMID: 33990905 DOI: 10.1007/s12031-021-01855-1.


Role of Autophagy in Cancer Cell Response to Nucleolar and Endoplasmic Reticulum Stress.

Pecoraro A, Pagano M, Russo G, Russo A Int J Mol Sci. 2020; 21(19).

PMID: 33020404 PMC: 7582989. DOI: 10.3390/ijms21197334.


The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response.

Camara-Quilez M, Barreiro-Alonso A, Vizoso-Vazquez A, Rodriguez-Belmonte E, Quindos-Varela M, Lamas-Maceiras M Cancers (Basel). 2020; 12(9).

PMID: 32867128 PMC: 7564582. DOI: 10.3390/cancers12092435.


References
1.
Vanhaesebroeck B, Leevers S, Ahmadi K, Timms J, Katso R, Driscoll P . Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem. 2001; 70:535-602. DOI: 10.1146/annurev.biochem.70.1.535. View

2.
Mora J, Cheung N, Chen L, Qin J, Gerald W . Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clin Cancer Res. 2001; 7(5):1358-61. View

3.
Cantley L . The phosphoinositide 3-kinase pathway. Science. 2002; 296(5573):1655-7. DOI: 10.1126/science.296.5573.1655. View

4.
Fox J, Ung K, Tanlimco S, Jirik F . Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J Immunol. 2002; 169(1):49-54. DOI: 10.4049/jimmunol.169.1.49. View

5.
Xiao A, Wu H, Pandolfi P, Louis D, Van Dyke T . Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell. 2002; 1(2):157-68. DOI: 10.1016/s1535-6108(02)00029-6. View